In the 10-K report, Liquidia Corporation reported a net loss of $130.4 million for the year ended December 31, 2024, compared ...

Corsair Pharma is planning a Phase 1 clinical trial of its treprostinil skin patch as a treatment for pulmonary arterial hypertension (PAH).

A new report from the NC Department of Health and Human Services on the programs around the state reveals that most counties have such programs – ones that give out clean syringes and other drug ...

Property News: This area has clocked the biggest annual boom in internal migration of any area in Australia. © 2025 Nine Entertainment Co.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The growth in Remodulin revenues resulted from an increase in U.S. Remodulin revenues and, to a lesser extent, an increase in international Remodulin revenues, driven, in both cases, by an ...